Although many tumor types express PSMA to certain extent [2–5], the applicability of PSMA as a diagnostic or therapeutic target will probably be limited to those which show a higher than average expression (see analysis of mRNA expression based on TCGA expression data on Figure 1). The gene discussed is FOLH1; the disease is neoplasm.